Monopar Therapeutics

(NASDAQ) MNPR

Current Price$63.04

Market Cap$422.84M

Since IPO (2019)-52%

5 Year+121%

1 Year+78%

1 Month+18%

Monopar Therapeutics Financials at a Glance

Market Cap

$422.84M

Revenue (TTM)

$0.00

Net Income (TTM)

$14.98M

EPS (TTM)

$-2.07

P/E Ratio

-30.55

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$63.04

Volume

2,841

Open

$62.23

Price

$63.04

Volume

2,841

Open

$62.23

Previous Close

$63.04

Daily Range

$61.15 - $64.03

52-Week Range

$28.40 - $105.00

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$63.04

Volume

2,841

Open

$62.23

Previous Close

$63.04

Daily Range

$61.15 - $64.03

52-Week Range

$28.40 - $105.00

MNPR News

No articles available.

MNPR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Monopar Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Chandler Drew Robinson, MD, MBA

Website

www.monopartx.com

Headquarters

Wilmette, IL 60091, US

MNPR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-16%

Return on Capital

-14%

Return on Assets

-11%

Earnings Yield

-3.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$422.84M

Shares Outstanding

6.70M

Volume

2.84K

Avg. Volume

187.81K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$16.70M

EBITDA

$16.70M

Operating Cash Flow

$12.20M

Capital Expenditure

$0.00

Free Cash Flow

$12.20M

Cash & ST Invst.

$140.40M

Total Debt

$154.92K

Monopar Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$422.84M

N/A

Market Cap/Employee

$30.20M

N/A

Employees

N/A

Net Income

$3.89M

-48.3%

EBITDA

$5.23M

-62.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$137.36M

+151.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$131.56K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-10.86%

N/A

Return on Invested Capital

-13.80%

N/A

Free Cash Flow

$3.47M

+38.7%

Operating Cash Flow

$3.47M

+38.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$8.60-1.04%

FULCFulcrum Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.$6.57-0.30%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$1.85+0.00%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$4.55+2.25%

CMPXCompass Therapeutics, Inc.

CMPXCompass Therapeutics, Inc.$2.07+7.25%

AKBAAkebia Therapeutics, Inc.

AKBAAkebia Therapeutics, Inc.$1.02+0.00%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.21+4.58%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$215.33-0.02%

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

Questions About MNPR

What is the current price of Monopar Therapeutics?

Monopar Therapeutics is trading at $63.04 per share.

What is the 52-week range for Monopar Therapeutics?

Over the past 52 weeks, Monopar Therapeutics has traded between $28.40 and $105.00.

How much debt does Monopar Therapeutics have?

As of the most recent reporting period, Monopar Therapeutics reported total debt of $131,565.

How much cash does Monopar Therapeutics have on hand?

Monopar Therapeutics reported $52.54M in cash and cash equivalents in its most recent financial results.

What is Monopar Therapeutics’s dividend yield?

Monopar Therapeutics does not currently have a dividend yield.

Monopar Therapeutics

Monopar Therapeutics Financials at a Glance

MNPR News

MNPR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Monopar Therapeutics

MNPR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Monopar Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MNPR

What is the current price of Monopar Therapeutics?

What is the 52-week range for Monopar Therapeutics?

How much debt does Monopar Therapeutics have?

How much cash does Monopar Therapeutics have on hand?

What is Monopar Therapeutics’s dividend yield?

Premium Investing Services